By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile  

6030 Avenida Encinas

Carlsbad  California  92009   U.S.A.
Phone: 760-602-7000 Fax: 760-602-8533



Company News
Cooper Pharma And BioQ Enter Into Strategic Partnership For Ropivacaine Readyfusor In Morocco 9/6/2017 11:00:45 AM
STADA Australia And BioQ Enter Into Strategic Partnership To Commercialize Three Ready-To-Use Infusion Products 8/23/2017 8:27:37 AM
BioQ Secures Up To $55 Million In Combined Debt And Equity Financing From Madryn Asset Management 8/15/2017 7:58:08 AM
BioQ And Lunatus Add A Third Infusion Pharmaceutical To Commercial Agreement Covering Arabian Gulf Area And Middle East 4/4/2017 11:56:30 AM
BioQ Receives Australian Regulatory Approval For Ropivacaine ReadyFusOR 3/14/2017 8:43:17 AM
Clinigen Signs Global Access Agreement For BioQ's Post-Operative Pain Management Product, Ropivacaine Readyfusor 12/15/2016 10:03:58 AM
BioQ Enters Into Strategic Partnership With Galen Limited To Commercialize Three Ready-To-Use Infusion Products In The United Kingdom And Ireland 12/6/2016 7:43:41 AM
BioQ And Cipla (CIPLA) Enter Into An Agreement To Commercialize BioQ’s Ropivacaine Infusion System In India 8/15/2016 3:26:07 PM
BioQ And Lunatus Execute Agreement To Commercialize Two Infusion Pharmaceuticals In Saudi Arabia, The United Arab Emirates, Qatar And Kuwait 12/2/2015 7:51:58 AM
BioQ To Present At The 26th Annual Oppenheimer Healthcare Conference 11/30/2015 8:15:09 AM